WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

Q3 2025 Management View Cedric Francois, CEO, highlighted the recent FDA approval of EMPAVELI for patients 12 years and older with C3 glomerulopathy and primary IC-MPGN, noting this expands EMPAVELI’s ...

Discover key Q3 2025 earnings insights for Travere Therapeutics, including FILSPARI sales growth, FDA milestones, and outlook for rare kidney ...

After claiming an FDA clearance last October, Paragonix Technologies reported that its donor kidney transportation system has completed its first commercial flight in a quick hop from Arizona to a ...

DALLAS, March 27, 2025 /PRNewswire/ — Medi-Ops, a technology-enabled medical logistics organization, and Southwest Transplant Alliance (STA), an organization committed to the advancement of transplant ...

Hospital-acquired acute kidney injury (HA-AKI) is a common complication in hospitalized patients that can lead to chronic kidney disease and is associated with longer hospital stays, higher health ...

Scientists at UC San Francisco are working on a new approach to treating kidney failure that could one day free people from needing dialysis or having to take harsh drugs to suppress their immune ...